Fate Therapeutics
FATE
FATE
180 hedge funds and large institutions have $401M invested in Fate Therapeutics in 2024 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
16.67% less ownership
Funds ownership: 123.99% → 107.32% (-17%)
56% less capital invested
Capital invested by funds: $903M → $401M (-$502M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
180
Holding in Top 10
–
Calls
$116K
Puts
$48K
Top Buyers
| 1 | +$4.48M | |
| 2 | +$4.45M | |
| 3 | +$4.42M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$3.94M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$3.87M |
Top Sellers
| 1 | -$18.8M | |
| 2 | -$18.6M | |
| 3 | -$11.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$8.85M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$6.51M |